Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles

PURPOSE: Lung cancer is the leading cause of cancer mortality worldwide. Drug resistance is the major barrier for the treatment of non-small cell lung cancer (NSCLC). The aim of this research is to develop an aptamer-decorated hybrid nanoparticle for the co-delivery of docetaxel prodrug (DTXp) and c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Wu, Ruifeng, Zhang, Zhiqiang, Wang, Baohua, Chen, Ge, Zhang, Yaozhong, Deng, Haowen, Tang, Zilong, Mao, Junjie, Wang, Lei
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7293388/
https://ncbi.nlm.nih.gov/pubmed/32606595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S246574
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi